VE-202
- Generic Name
- VE-202
VE202 in Patients With Mild-to-Moderate Ulcerative Colitis
Phase 2
Active, not recruiting
- Conditions
- Ulcerative ColitisColitis, Ulcerative
- Interventions
- First Posted Date
- 2022-05-12
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Vedanta Biosciences, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT05370885
- Locations
- 🇺🇦
Medical Center OK!Clinic+, Kyiv, Ukraine
🇺🇸Clinical Applications Laboratories, San Diego, California, United States
🇺🇸GI Pros Research, Naples, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath